Dora Ferrari
Corporate Officer/Principal bei CURIS, INC.
Profil
Dora Ferrari is currently the Vice President-Clinical Operations at Curis, Inc. Prior to this, she worked as the Director-Clinical Development & Program Management at ArQule, Inc., a Clinical Research Associate at EPIX Pharmaceuticals, Inc., and the VP-Clinical Development & Program Management at Aileron Therapeutics, Inc. She completed her undergraduate degree at the University of Massachusetts.
Aktive Positionen von Dora Ferrari
| Unternehmen | Position | Beginn |
|---|---|---|
| CURIS, INC. | Corporate Officer/Principal | 03.01.2021 |
Ehemalige bekannte Positionen von Dora Ferrari
| Unternehmen | Position | Ende |
|---|---|---|
| ARQULE, INC. | Corporate Officer/Principal | - |
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Corporate Officer/Principal | - |
| AILERON THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Dora Ferrari
| University of Massachusetts | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AILERON THERAPEUTICS, INC. | Health Technology |
| CURIS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Health Technology |
